LEVETIRACETAM TEVA ® 250 MG

Země: Izrael

Jazyk: angličtina

Zdroj: Ministry of Health

Aktivní složka:

LEVETIRACETAM 250 MG

Dostupné s:

TEVA PHARMACEUTICAL INDUST.LTD

ATC kód:

N03AX14

Léková forma:

TABLETS

Podání:

PER OS

Výrobce:

TEVA PHARMACEUTICAL INDUSTRIES LTD

Terapeutické skupiny:

LEVETIRACETAM

Terapeutické indikace:

- Levetiracetam is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - Levetiracetam is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.- Levetiracetam is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patient from 16 years of age with newly diagnosed epilepsy.- Levetiracetam is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

Datum autorizace:

2009-09-01